STR 324
Alternative Names: STR-324Latest Information Update: 28 Mar 2021
At a glance
- Originator Institut Pasteur
- Developer Stragen Pharma SA
- Class Analgesics; Non-opioid analgesics; Peptides
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Postoperative pain
Most Recent Events
- 28 Mar 2021 No recent reports of development identified for phase-I development in Pain(In volunteers) in Netherlands (IV, Infusion)
- 01 Dec 2020 Phase-II clinical trials in Postoperative pain in Netherlands (IV) (NCT04582786)
- 28 Oct 2019 No recent reports of development identified for preclinical development in Pain in France (IV, Infusion)